Amy Chadburn, MD

Highlights

1
American journal of clinical pathology · 2025
ACAmy Chadburn
PMID: 40619129DOI eCommonsSenior author5 citations

267

7

7 grants

Co-I
Consortium for Advancing Management and Prevention of Cancer in People with HIV - RESOURCE LAB
National Cancer Institute · 2015–2030 · via EMMES Corporation· 3 renewals
UM1CA121947-19
Co-I
B cell determinants of EBV latency
National Cancer Institute · 2022–2027
U01CA275301-01
Co-I
Clinical and Translational Science Center- Institutional CTSC Internal Funding UL1
CTSC Cost Share · 2022–2027
UL1TR002384-06
Co-I
Regulatory Crosstalk Between Human Endogenous Retroviruses, HIV, and EBV, in Lymphoma
National Cancer Institute · 2021–2027 · via Northwell Health· 2 renewals
R01CA260691-04
KP
Biomarkers of response in primary mediastinal B-cell lymphoma: Defining tumor microenvironment signatures
Hyundai Hope on Wheels Foundation · 2024–2026
HHWF 240412-01
Co-I
(PQ 6) New Models of KSHV Oncogenesis and KS Immune Environment
National Cancer Institute · 2020–2026
R01CA250074-01
Co-I
Evaluating Biologic Mechanisms of Racial and Ethnic Disparities in Pediatric Hodgkin Lymphoma
National Cancer Institute · 2024–2026 · via Children's Oncology Group
5 UG1 CA233249- 06

United States and Canadian Academy of Pathology

United States and Canadian Academy of Pathology

Alliance for Clinical Trials in Oncology · Lymphoma Research Foundation

Lymphoma Research Foundation · United Healthcare Services, Inc. · United States and Canadian Academy of Pathology

United States and Canadian Academy of Pathology